RMH Holdings Limited (8437.HK)

HKD 0.17

(-0.58%)

EBITDA Summary of RMH Holdings Limited

RMH Holdings Limited's latest annual EBITDA in 2023 was -4.99 Million SGD , up 4.99% from previous year.
RMH Holdings Limited's latest quarterly EBITDA in 2024 Q2 was 525.5 Thousand SGD , down 0.0% from previous quarter.
RMH Holdings Limited reported an annual EBITDA of -7.83 Million SGD in 2022, up 13.23% from previous year.
RMH Holdings Limited reported an annual EBITDA of -2.58 Million SGD in 2021, down -34.48% from previous year.
RMH Holdings Limited reported a quarterly EBITDA of 525.5 Thousand SGD for 2024 Q2, down 0.0% from previous quarter.
RMH Holdings Limited reported a quarterly EBITDA of -3 Million SGD for 2023 Q1, down -43.98% from previous quarter.

Annual EBITDA Chart of RMH Holdings Limited (2023 - 2015)

Historical Annual EBITDA of RMH Holdings Limited (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	-4.99 Million SGD	4.99%
2022	-7.83 Million SGD	13.23%
2021	-2.58 Million SGD	-34.48%
2020	-6.47 Million SGD	-233.35%
2019	1.82 Million SGD	-20.1%
2018	2.28 Million SGD	1839.83%
2017	118 Thousand SGD	-96.48%
2016	3.27 Million SGD	13.24%
2015	2.8 Million SGD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	525.5 Thousand SGD	120.63%
2024 Q2	525.5 Thousand SGD	0.0%
2023 Q1	-3 Million SGD	-43.98%
2023 Q3	-636 Thousand SGD	-37.07%
2023 Q4	-2.54 Million SGD	-300.47%
2023 Q2	-464 Thousand SGD	84.54%
2023 FY	- SGD	4.99%
2022 Q2	-1.35 Million SGD	13.31%
2022 FY	- SGD	13.23%
2022 Q4	-2.08 Million SGD	-2012.84%
2022 Q3	109 Thousand SGD	108.04%
2022 Q1	-1.56 Million SGD	15.42%
2021 Q3	-361 Thousand SGD	66.67%
2021 Q4	-1.84 Million SGD	-411.91%
2021 FY	- SGD	-34.48%
2021 Q2	-1.08 Million SGD	-875.68%
2021 Q1	-111 Thousand SGD	90.88%
2020 Q2	-349 Thousand SGD	-158.17%
2020 Q1	600 Thousand SGD	1528.57%
2020 FY	- SGD	-233.35%
2020 Q4	-1.21 Million SGD	-248.78%
2020 Q3	818 Thousand SGD	334.38%
2019 FY	- SGD	-20.1%
2019 Q1	748 Thousand SGD	183.33%
2019 Q4	-42 Thousand SGD	-105.48%
2019 Q3	766 Thousand SGD	31.39%
2019 Q2	583 Thousand SGD	-22.06%
2018 Q2	969 Thousand SGD	128.54%
2018 Q1	424 Thousand SGD	156.01%
2018 FY	- SGD	1839.83%
2018 Q4	264 Thousand SGD	-58.23%
2018 Q3	632 Thousand SGD	-34.78%
2017 Q2	-179 Thousand SGD	-156.83%
2017 FY	- SGD	-96.48%
2017 Q4	-757 Thousand SGD	-199.74%
2017 Q3	759 Thousand SGD	524.02%
2017 Q1	315 Thousand SGD	-48.45%
2016 FY	- SGD	13.24%
2016 Q4	611 Thousand SGD	0.0%
2016 Q1	897 Thousand SGD	0.0%
2015 FY	- SGD	0.0%

Peer EBITDA Comparison of RMH Holdings Limited

Name	EBITDA	EBITDA Difference
Aidigong Maternal & Child Health Limited	68.84 Million HKD	107.255%
UMP Healthcare Holdings Limited	161.98 Million HKD	103.084%
Human Health Holdings Limited	104.06 Million HKD	104.8%
EuroEyes International Eye Clinic Limited	292.1 Million HKD	101.71%
Kato (Hong Kong) Holdings Limited	133.61 Million HKD	103.738%
Bamboos Health Care Holdings Limited	52.75 Million HKD	109.468%
Beijing Health (Holdings) Limited	-44.19 Million HKD	88.697%
C-MER Eye Care Holdings Limited	359.88 Million HKD	101.388%
Town Health International Medical Group Limited	53.5 Million HKD	109.336%
Medicskin Holdings Limited	6.77 Million HKD	173.716%
Hang Chi Holdings Limited	81.58 Million HKD	106.122%